Matches in Nanopublications for { ?s ?p ""1. Hepatic or severe renal dysfunction, including primary biliary cirrhosis. 2. Preexisting gallbladder disease (see WARNINGS 3. Hypersensitivity to gemfibrozil. 4. Combination therapy of gemfibrozil with simvastatin (see WARNINGS PRECAUTIONS 5. Combination therapy of gemfibrozil with repaglinide (see PRECAUTIONS 6. Combination therapy of gemfibrozil with dasabuvir (see PRECAUTIONS 7. Combination therapy of gemfibrozil with selexipag (see PRECAUTIONS"" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""1. Hepatic or severe renal dysfunction, including primary biliary cirrhosis. 2. Preexisting gallbladder disease (see WARNINGS 3. Hypersensitivity to gemfibrozil. 4. Combination therapy of gemfibrozil with simvastatin (see WARNINGS PRECAUTIONS 5. Combination therapy of gemfibrozil with repaglinide (see PRECAUTIONS 6. Combination therapy of gemfibrozil with dasabuvir (see PRECAUTIONS 7. Combination therapy of gemfibrozil with selexipag (see PRECAUTIONS"" assertion.